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ABSTRACT 
Objective: The purpose of this study was to monitor the intensity and difference in Peak Expiratory Flow Rate (PEFR) between smokers and 
passive smokers. 
Methods: A total of 1000 participants were enrolled in two groups as smokers and passive smokers who are living closely with smokers. Their 
PEFR values were measured with Wright’s mini peak flow meter. The influence of smoking on the lung function among smokers and passive 
smokers were assessed with a suitable statistical test. 
Results: Among the study participants, most of the smokers were in the age group of 31 to 60 and 31 to 50 in passive smokers. Based on the lung 
function smokers (31%) and passive smokers (19.2%) were in the red zone, PEFR was decreased in both smokers as well as passive smokers, and 
the magnitude of decline was higher in passive smoking elderly individuals. The impact of passive smoking was significantly observed in all the 
categories of smoking history they are living with. 
Conclusion: Smokers and passive smokers have equally deleterious effects on PEFR. Where passive smoking emerged as the main variable to 
influence airway obstruction in smokers that caused a greater reduction in PEFR. 
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Tobacco use is the leading cause of death and according to the WHO 
report on the global tobacco epidemic, in 2017 there were 2.7 billion 
people still lacking protection from the illness, disability, and death 
caused by tobacco use and second-hand smoke exposure [1]. WHO 
estimated that almost one-half of the world’s children (nearly 700 
million) are exposed to tobacco smoke from the adults, where the 
major exposure takes place at home [2]. About 40% of children, 33% 
of male non-smokers and 35% of female non-smokers were exposed 
to second-hand smoke in 2004 globally [3]. 
Passive smoking or environmental tobacco smoke (ETS) exposure 
has been variously described as ‘second-hand smoke’ or ‘involuntary 
smoking’. An exhaustive report on health consequences of 
involuntary smoking highlighted the increased risks of several 
diseases similar to those seen among smokers; in persons exposed 
to ETS at home or a workplace [4]. There are very few reports on the 
health effects of ETS from the developing and the underdeveloped 
countries. Children exposed to second-hand smoke may lead to 
respiratory illnesses as a result of adverse effects on their immune 
system and lung growth and development [5].  
Passive smoking exposure was estimated worldwide to have caused 
deaths from ischemic heart disease, lower respiratory infections, 
asthma, and lung cancer, there were 6,03,000 deaths attributable to 
it in 2004 which was about 1.0% of worldwide mortality [3]. It was 
reported that the increasing risk and dose relationship for 
respiratory symptoms related to total ETS exposure [6] which has 
been estimated that second-hand smoke is responsible for each year 
22,000 hospitalizations between 1,50,000 and 3,00,000 cases of 
bronchitis and pneumonia and between 8,000 and 26,000 cases of 
asthma [7]. 
Tobacco smoking is a major risk factor for cardiovascular disease, 
COPD, and some cancers [8] where the morbidity and mortality with 
tobacco use is entirely preventable. The death toll from tobacco use 
is projected to rise worldwide from 5.4 million in 2004 to 8.3 million 
in 2030 [9]. Tobacco smoking in Indian males is much higher (19%) 
than females (2%) and 38.7% of adults were exposed to second-
hand smoke at home according to Global Adult Tobacco Survey 2 
(GATS 2) India 2016-17 Report [10]. It is interesting to note that 
though the prevalence of cigarette smoking in rural areas is lower 
than in urban areas, the number of cigarette smokers in rural areas 
are higher than in urban areas. 
Several studies have reported that PEFR was significantly lowered in 
smokers than in non-smokers and some studies found a maximum 
reduction in PEFR among beedi smokers than cigarette smokers. 
High prevalence for both cigarette and cigar smoking in the region, 
inconsistent findings, and the lack of literature relating the smoking 
and PEFR prompted us to take up the present study [11]. The 
objective of the study was to investigate the extent of PEFR affected 
among smokers and passive smokers. 
MATERIALS AND METHODS  
All the study procedures were performed with the approval of the 
Institutional Research Council and the Institutional Human Ethics 
Committee (Protocol number: 5/PD1). The study population was 
selected irrespective of gender and age with the written consent to 
participate in this study. The study participants were categorized 
into two groups as smokers and passive smokers. Smokers were 
recruited based on their self-reported smoking status and the 
person living with the smokers; who don’t smoke were included in 
passive smokers group based on their exposure to smoke. A total of 
500 smokers and 500 passive smokers were included as quota 
sampling.  
The respiratory problems, peak flow rate and their knowledge on 
passive smoking were assessed; the data were collected from the 
participant and then entered in a pre-designed data collection form 
which includes participant’s demographics such as age, smoking 
status, history and details of respiratory problems. The individual 
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peak expiratory flow rate was measured using Wright’s peak flow 
meter [12]. Peak expiratory flow rates for two different groups such 
as smokers and passive smokers were assessed individually. 
In this study, peak flow meter was used to assess the peak 
expiratory flow rate. The subject was allowed to stand in an upright 
position and the meter was placed horizontally in front of the mouth. 
At first, the subject was allowed to take a deep breath in by firmly 
closing the lips around the mouthpiece making sure that there is no 
leakage of air around the lips and is allowed to breathe out the air as 
fast as possible. Cursor reading [PEFR value] was recorded and the 
cursor was reset to zero and the same above procedure was 
repeated for two more times for obtaining the total three readings. 
Subjects were categorized into three different zones based on the 
markings and readings of the peak flow meter. The PEFR value of 
150-250 l/min was considered as red zone (danger zone) indicating 
that the participant is in high risk, yellow zone (caution zone) with 
PEFR value of 250–350 l/min signals caution the narrowing of 
airways and green zone (clear zone) with PEFR value more than 350 
l/min indicates normal peak flow.  
All the data were entered in Microsoft Excel and analyzed using 
Graph pad prism version 7.0. Continuous variables (age, smoking 
history, PEFR) were represented as mean±Standard Deviation and 
categorical variables (educational level, respiratory problems) were 
represented as frequency (%). To evaluate the impact of smoking 
and passive smoking on lung function Pearson correlation analysis 
was done. 
RESULTS AND DISCUSSION 
Passive smoking is known to be deleterious for human health as 
compared with first-hand smoking, especially the respiratory 
system; therefore it is important to identify the risk for individual 
second-hand smokers and to create awareness among them. This 
study is conducted to create awareness among passive smokers 
about the risk involved and how to avoid it by assessing their 
knowledge about passive smoking. A total of 1000 subjects were 
included in the study classified according to their self-reported 
status as smokers [n = 500] and passive smokers [n = 500]. The 
subjects included as passive smokers were those who were exposed 
to cigarette smoke at home or the workplace. All the study subjects 
for passive smoking and the non-smoking group were female and 
the cause of passive smoking is by their husband.  
Age-wise distribution among the study participants shows most of 
the smokers [54.2%] are in between 31-60 y of age, most [59%] of 
the passive smokers are in between 31–50 y of age. Previously 
conducted research shows that there was the highest prevalence 
reported in men aged 40–49 y [12]. Among the study participants 
31% of smokers, 19.2% of passive smokers were in the red zone 
[PEFR = 150–250 l/min] indicating abnormal lung function, which 
shows the extent of the problem among the smokers and passive 
smokers. Previously conducted research shows that cigarette 
smoking or exposure to it had an impact on PEFR [11, 14].  
Table 1 shows the impact of smoking on lung function among 
smokers and passive smokers who are staying with them. The study 
result shows that increasing smoking history is strongly associated 
with the decrease in PEFR for both the smokers and passive 
smokers, which is probably because the variable was dependent on 
the expiratory effort and the elastic recoil of the lungs and the 
airway size, factors which are known to reduce with advancing age. 
Also, there may be possible reasons for the decrease in PEFR as 
inflammation which is common and a constant pathological finding 
in cigarette smokers and the gender and age-related effect. 
Previously conducted research shows that there exists a strong 
correlation between the intensity of cigarette/cigar smoking and 
PEFR i.e. the greater the intensity of cigarette/cigar smoking, the 
lesser the PEFR value [11]. Smoking is a very well-known cause for 
conditions such as emphysema, COPD and chronic bronchitis; where 
the risk increases with the pack-years [15]. Smokers have a steeper 
decline in FEV1 who on average had a decline of 25–30 ml a year 
[16]. It should be taken into consideration also the extent of the 
passive smoker's lung function decline. In this study, the impact of 
smoking on lung function is almost equal in passive smokers like 
smokers which bring in a major concern for the involuntary smoking 
group also. It is important to note that the chances for second-hand 
smoke exposure are high in home than any others (such as 
workplace, restaurants, public transportation, etc.,) [10] there is a 
need to bring in the awareness among the smokers and also their 
family members, which can avoid the chances for the passive 
smoking exposure. 
  
Table 1: Impact of smoking on lung function (PEFR) 
Smoking 
history (years) 
Smoker (n = 500) Passive smoker (n = 500) 
PEFR (l/min) (mean±SD) R2 p value¥ PEFR (l/min) (mean±SD) R2 p value¥ 
1–10 346±62.78 0.06827 0.0004* 308±48.01 0.08044 0.0001* 
11-20 291.4±57.04 0.02726 0.0390* 295.7±48.07 0.03858 0.0100* 
21-30 269.7±56.47 0.1248 0.0027* 266.1±53.99 0.08905 0.0121* 
31-40 249.2±60.33 0.1356 0.0078* 246.6±50.01 0.08905 0.0327* 
41-50 229.2±57.51 0.2616 0.0054* 224.5±21.38 0.3868 0.0004* 
*p<0.05¥Pearson correlation analysis 
 
CONCLUSION 
There are deleterious effects on lung function among both the 
smokers and passive smokers causing a reduction in PEFR. Passive 
smokers also have equal harms as compared to first-hand smokers, 
which brings the need to be cautious in the environment. 
Considering this the health policies may be adopted by banning 
smoking in public places.  
FINANCIAL SUPPORT AND SPONSORSHIP 
Nil 
AUTHORS CONTRIBUTIONS 
All the authors have contributed equally 
CONFLICTS OF INTERESTS 
All the authors declare no any conflicts of interest 
REFERENCES 
1. World Health Organization (WHO) report on the Global 
Tobacco Epidemic; 2017. Available from: http://www.who.int/ 
tobacco/global_report/en/. [Last accessed on 20 May 2018] 
2. Avsar A, Darka O, Topaloglu B, Bek Y. Association of passive 
smoking with carries and related salivary biomarkers in young 
children. Arch Oral Biol 2008;53:969-74. 
3. Oberg M, Peruga A, Pruss Ustun A, Sjaakkola M, Woodward A. 
Worldwide burden of disease from exposure to second-hand 
smoke: a retrospective analysis of data from 192 countries. 
Lancet 2011;377:139-46. 
4. Office on Smoking and Health (US). The Health Consequences of 
Involuntary Exposure to Tobacco Smoke: A Report of the 
Surgeon General. Atlanta (GA): Centers for Disease Control and 
Prevention (US); 2006. Available from: https://www.ncbi. 
nlm.nih.gov/books/NBK44324/. [Last accessed on 10 Mar 2018]  
5. US EPA. Respiratory health effects of passive smoking: lung 
cancer and other disorders. U. S. Environmental Protection 
Agency, Office of Research and Development, Office of Health 
Ganesh et al. 
Int J Pharm Pharm Sci, Vol 11, Issue 11, 17-19 
19 
and Environmental Assessment, Washington, DC, EPA/600/6-
90/006F; 1992. 
6. Jansson C, Chinn S, Jarvis D, Zock JP, Toren K, Burney P. Effects 
of passive smoking on respiratory symptoms, bronchial 
responsiveness, lung function, and total IgE in the European 
Community respiratory health survey: a cross-sectional study. 
Lancet 2001;358:2103–9. 
7. What's new in nicotine and tobacco research? Nicotine Tobacco 
Research 2003;5:281-7. Available from:   https://doi.org/ 
10.1080/1462220031000095717 [Last accessed on 10 Jul 
2019]. 
8. Nida BSA, Natasha H, Nahlah EI. Smoking status affecting 
survival of adenocarcinoma lung cancer patients in Kuala 
Lumpur, Malaysia. Asian J Pharm Clin Res 2017;10:312-3. 
9. Mathers CD, Loncar D. Projections of global mortality and 
Barden of disease from 2002 to 2030. Plos Med 2006;3:e442. 
10. World Health Organization, CDC. Global Adult Tobacco Survey 
2 (GATS 2): India factsheet; 2016-2017. Available from: 
http://www.who.int/tobacco/surveillance/survey/gats/GATS_
India_2016-17_FactSheet. pdf?ua=1. [Last accessed on 10 Jun 
2018]. 
11. Tambi M, Rao BN, Glad MMI, Praveen KM. Effect of cigar and 
cigarette smoking on peak expiratory flow rate. J Clin 
Diagnostic Res 2013;7:1886-9. 
12. Wright BM, McKerrow CB. Maximum forced expiratory flow 
rate as a measure of ventilatory capacity: with a description of 
a new portable instrument for measuring it. Br Med J 
1959;2:1041-6. 
13. Omair A, Kazmi T, Alam S. Smoking prevalence and 
awareness about tobacco related diseases among medical 
students of Ziauddin Medical University. J Pak Med Assoc 
2002;52:389-92. 
14. Jain SK, Rajendra K, Sharma DA. Factors influencing peak 
expiratory flow rate in normal subjects-II. Lung India 
1983;1:92-7. 
15. Forey BA, Thornton AJ, Lee PN. Systematic review with meta-
analysis of the epidemiological evidence relating smoking to 
COPD, chronic bronchitis and emphysema. BMC Pulm 
Med 2011;11:36.
 
